Endocrinological late complications after hematopoietic SCT in children

Bone Marrow Transplantation

Volumn 41, Issue SUPPL. 2, 2008, Pages

  Cohen, A ^a   Bekassy A N ^b   Gaiero, A ^a   Faraci, M ^c   Zecca, S ^a   Tichelli, A ^d   Dini, G ^c  

^a UNIVERSITY OF GENOA   (Italy)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c G GASLINI INSTITUTE   (Italy)

^d UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; ANTINEOPLASTIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; BUSULFAN; CORTISONE; CYCLOPHOSPHAMIDE; ESTROGEN; GESTAGEN; GROWTH HORMONE; IMMUNOSUPPRESSIVE AGENT; LEVOTHYROXINE; SEX HORMONE;

ACUTE GRANULOCYTIC LEUKEMIA; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHILD GROWTH; CHILDHOOD CANCER; CHRONIC MYELOID LEUKEMIA; DIABETES MELLITUS; DRUG MEGADOSE; DRUG SAFETY; ENDOCRINE DISEASE; FERTILIZATION IN VITRO; FOLLOW UP; GRAFT VERSUS HOST REACTION; GROWTH DISORDER; GROWTH HORMONE DEFICIENCY; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HORMONAL THERAPY; HUMAN; HYPERGONADOTROPIC HYPOGONADISM; HYPOTHYROIDISM; INCIDENCE; INFERTILITY; OSTEOPENIA; OVARY INSUFFICIENCY; OVULATION INDUCTION; PREMATURITY; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RISK BENEFIT ANALYSIS; RISK REDUCTION; SEXUAL MATURATION; SURVIVAL RATE; TESTIS INJURY; THYROID DISEASE; WHOLE BODY RADIATION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; ENDOCRINE SYSTEM DISEASES; FEMALE; GROWTH DISORDERS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; PUBERTY, DELAYED; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS;

EID: 45749091856     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2008.54     Document Type: Review

References (35)

1. Coebergh JW, Capocaccia R, Gatta G, Magnani C, Stiller CA. Childhood cancer survival in Europe 1978.1992: The EURO-CARE Study. Eur J Cancer 2001; 37: 671-816.
2. Ries LAG, Smitrh MA. Gurney JG et al. (eds). Cancer incidence and survival among children and adolescents: United States SEER program 1975-1995. National Cancer Institute: Bethesda, MD, 1999.
3. Bleyer WA. The impact of childhood cancer on the United States and the world. CA Cancer J Clin 1990; 40: 355-670.
4. Kupst MJ, Penati B, Debban B, Camitta B, Pietryga D, Margolis D et al Cognitive and psychosocial functioning of pediatric hematopoietic stem cell transplant patients: A prospective longitudinal study. Bone Marrow Transplant 2002; 30: 609-617.
5. Michel G, Socie G. Gebhard F, Bernaudin F, Thuret I, Vannier JP et al Late effects of allogeneic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: The impact of conditioning regimen without total-body irradiation-a report from the Societe Francaise de Greffe de Moelle. J Clin Oncol 1997; 15 2238-2246.
6. Oeffinger KC, Hudson MM. Long-term complications following childhood and adolescent cancer: Foundations for providing risk-based health care for survivors. CA Cancer J Clin 2004; 54: 208-236.
7. Phipps S, Dunavant M, Srivastava DK, Bowman L, Mulhern RK. Cognitive and academic functioning in survivors of pediatric bone marrow transplantation. J Clin Oncol 2000: 18: 1004-1011.
8. McCann S, Apperley J, Cohen A, Kolb HJ, Socie G. for the Late Effects Working Party of the European Group for Blood and Marrow Transplantation. Late effects of transplantation. Lancet 1999; 8: 353.
9. Socié G, Salooja N, Cohen A, Rovelli A, Carreras E, Locasciulli A, et al., for the Late Effect Working Party of the European Group for Blood and Marrow Transplantation. Nonmalignant late effects after allogeneic stem cell transplantation, Review Article. Blood 2003; 101: 3373-3385.
10. Cohen A, Rovelli A, Van-Lint MT, Uderzo C, Morchio A, Pezzini C et al Final height of patients who underwent bone marrow transplantation for haematological disorders during childhood: A study by the Working Party for Late Effects - EBMT. Blood 1999; 93: 4109-4115.
11. Afify Z, Shaw PJ, Clavano-Harding A, Cowell CT. Growth and endocrine function in children with acute myeloid leukaemia after bone marrow transplantation using busulfan/cyclophosphamide. Bone Marrow Transplant 2000; 25: 1087-1092.
12. Chemaitilly W, Boulad F, Heller G, Kernan NA, Small TN, O'reilly RJ et al. Final height in pediatric patients after hyperfractionated total body irradiation and stem cell transplantation. Bone Marrow Transplant 2007; 40: 29-35.
13. Bakker B, Oostdijk W, Geskus RB, Stokvis-Brantsma WH, Vossen JM, Wit JM. Pattern of growth and body proportions after total body irradiation and hematopoietic stem cell transplantation during childhood. Pediatr Res 2006; 59: 259-264.
14. Sanders JE, Guthrie KA, Hoffmeister PA, Woolfrey AE. Carpenter PA, Appelbaum FR. Final adult height of patients who received hematopoietic cell transplantation in childhood. Blood 2005; 105: 1348-1354.
15. Sklar CA, Mertens AC, Mitby P, Occhiogrosso G, Qin J, Heller G et al Risk of disease recurrence and second neoplasms in survivors of childhood cancer treated with growth hormone: A report from the Childhood Cancer Survivor Study. J Clin Endocrinol Metab 2002; 87: 3136-3141.
16. Curtis RE, Rowlings PA, Deeg HJ, Shriner DA, Socie G, Travis LB et al Solid cancers after bone marrow transplantation. N Eng J Med 1997; 336: 897-904.
17. Deeg HJ, Socie G. Malignancies after hematopoietic stem cell transplantation: Many questions, some answers. Blood 1998; 91 1833-1844.
18. Teinturier C, Hartmann O, Valteau-Couanet D, Benhamou E, Bougneres PF. Ovarian function after autologous bone marrow transplantation in childhood: High-dose busulfan is a major cause of ovarian failure. Bone Marrow Transplant 1998; 22: 989-994.
19. Sanders JE, Hawley J, Levy W, Gooley T, Buckner CD, Deeg HJ et al. Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. Blood 1996; 87: 3045-3052.
20. Thibaud E, Rodriguez-Macias K, Trivin C, Espérou H. Michon J, Brauner R. Ovarian function after bone marrow transplantation during childhood. Bone Marrow Transplant 1998; 21: 287-290.
21. Chatterjee R, Mills W. Katz M, McGarrigle HH, Goldstone AH. Germ cell failure and Leydig cell insufficiency in post-pubertal males after autologous bone marrow transplantation with BEAM for lymphoma. Bone Marrow Transplant 1994; 13: 519-522.
22. Howell SJ, Radford JA, Shalet SM. Testicular function following cytotoxic chemotherapy: Evidence of Leydig cell insufficiency. J Clin Oncol 1999; 17: 1493-1498.
23. Wallace WHB, Thompson AB, Kelsey TW. Radiosensitivity of the human oocyte. Hum Reprod 2003; 18: 117-121.
24. Spinelli S, Chiodi S, Bacigalupo A, Brasca A, Menada MV, Petti AR et al. Ovarian recovery after total body irradiation and allogeneic bone marrow transplantation: Long-term follow up of 79 females. Bone Marrow Transplant 1994; 14: 373-380.
25. Sanders JE, Buckner CD, Amos D, Levy W, Appelbaum FR, Doney K et al Ovarian function following marrow transplantation for aplastic anemia or leukaemia. J Clin Oncol 1988; 6: 813-818.
26. Salooja N, Szydlo RM, Socie G, Rio B, Chatterjee R, Ljungman P et al Pregnancy outcomes after peripheral blood or bone marrow transplantation: A retrospective survey. Lancet 2001; 358: 271-276.
27. Borgstrom B, Bolme P. Thyroid function in children after allogeneic bone marrow transplantation. Bone Marrow Transplant 1994; 13: 59-64.
28. Boulad F, Bromley M, Black P, Heller G, Sarafoglou K, Gillio A et al Thyroid dysfunction following bone marrow transplantation using hyperfractionated radiation. Bone Marrow Transplant 1995; 15 71-76.
29. Aldouri MA, Ruggier R, Epstein O, Prentice HG. Adoptive transfer of hyperthyroidism and autoimmune thyroiditis following allogeneic bone marrow transplantation for chronic myeloid leukaemia. Br J Haematol 1990; 74: 118-119.
30. Berisso GA, Van Lint MT, Bacigalupo A, Marmont AM. Adoptive autoimmune hyperthyroidism following allogeneic stem cell transplantation from an HLA-identical sibling with Graves disease. Bone Marrow Transplant 1999: 23: 1091-1092.
31. Cohen A, Rovelli A, Merlo F, van Lint MT, Lanino E, Bresters D, et al., for the Late-Effects Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Risk for secondary thyroid carcinoma after hematopoietic stem cell transplantation: An EBMT Late Effects Working Party Study. J Clin Oncol 2007; 25: 2449-2454.
32. Taskinen M, Saarinen-Pihkala UM, Hovi L, Lipsanen-Nyman M. Impaired glucose tolerance and dyslipidaemia as late effects after bone-marrow transplantation in childhood. Lancet 2000; 356: 993-997.
33. Traggiai C, Stanhope R, Nussey D, Leiper AD. Diabetes mellitus after bone marrow transplantation during childhood. Med Pediatr Oncol 2003; 40: 128-129.
34. Hoffmeister PA, Storer BE, Sanders JE. Diabetes mellitus in long-term survivors of pediatric hematopoietic cell transplantation. J Pediatr Hematol Oncol 2004; 26: 81-90.
35. Bonanomi S, Gaiero A, Masera N, Rovelli A, Uderzo C, Fichera G et al Distinctive characteristics of diabetes mellitus after hematopoietic cell transplantation during childhood. Pediatr Transplant 2006; 10: 461-465.